SENSILE
LIVE

Serial Number

79371736

Owner

Sensile Medical AG

Attorney

Andrew M. Smith

Filing Date

May 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SENSILE Trademark

Serial Number: 79371736 • Registration: 7464631

SENSILE is a trademark filed by Sensile Medical AG on May 15, 2023. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Sensile Medical AG (5 trademarks)

Fabrikstrasse 10

Entity Type: 99

Trademark Details

Filing Date

May 15, 2023

Registration Date

August 6, 2024

Published for Opposition

May 21, 2024

Goods & Services

medical apparatus and instruments, namely, electromagnetic drug delivery apparatus for medical use, infusion and injection devices for administering drugs, drug delivery ports and pumps for delivering drugs beneath the skin; apparatus for blood and blood plasma analysis, apparatus for blood extraction and blood analysis, namely, hematology analyzers, hematology rheometers, blood gas analyzers, biochemistry analyzers, hemagglutinators, and chemiluminescence immunoassay analyzers for medical diagnostic uses; diagnostics and analysis apparatus for medical purposes, in particular blood glucose meters, devices for measuring glycaemia, namely, glocometers, and glycerin concentration meters; medical apparatus for introducing pharmaceutical preparations into the body, in particular apparatus for introducing insulin and glucagon, namely, jet injectors for medical purposes, and portable pumps and patch pumps for medical use, in particular mobile and portable pumps and patch pumps for the transcutaneous and subcutaneous administering of drugs and active ingredients for diabetes management, for the treatment of degenerative disorders of the central nervous system, and for therapies that periodically require the delivery of a certain total quantity of a formulated drug; insulin and glucagon pumps; belts for medical purposes; injection devices for medical purposes, namely, infusion pumps, syringes for injections, medical fluid injectors for transcutaneous and subcutaneous delivery of medication including insulin and glucagon, and brush pens and dispensation devices in the form of injection instruments with needles for accurate, precise dosing and application of medical or cosmetic creams and preparations; insulin and glucagon injection instruments with needles; medical test kits for diabetes monitoring for home or clinical use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Aug 19, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 21, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 31, 2025 FICS
FINAL DISPOSITION PROCESSED
Jan 31, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 6, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 6, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 6, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
REFUSAL PROCESSED BY IB
Apr 22, 2024 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 17, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 17, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 17, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 17, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2024 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 14, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 14, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 23, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 22, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 8, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 3, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 29, 2023 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 8, 2023 SDRC